137 related articles for article (PubMed ID: 38879502)
41. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.
Rohrer JD; Lashley T; Schott JM; Warren JE; Mead S; Isaacs AM; Beck J; Hardy J; de Silva R; Warrington E; Troakes C; Al-Sarraj S; King A; Borroni B; Clarkson MJ; Ourselin S; Holton JL; Fox NC; Revesz T; Rossor MN; Warren JD
Brain; 2011 Sep; 134(Pt 9):2565-81. PubMed ID: 21908872
[TBL] [Abstract][Full Text] [Related]
42. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
43. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
[TBL] [Abstract][Full Text] [Related]
44. Frontotemporal lobar degeneration: new understanding brings new approaches.
Tartaglia MC
Neuroimaging Clin N Am; 2012 Feb; 22(1):83-97, viii. PubMed ID: 22284735
[TBL] [Abstract][Full Text] [Related]
45. Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
Gittings LM; Foti SC; Benson BC; Gami-Patel P; Isaacs AM; Lashley T
Acta Neuropathol Commun; 2019 Feb; 7(1):18. PubMed ID: 30755280
[TBL] [Abstract][Full Text] [Related]
46. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
Irwin DJ; Lleó A; Xie SX; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018
[TBL] [Abstract][Full Text] [Related]
47. TDP-43 and FUS: a nuclear affair.
Dormann D; Haass C
Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347
[TBL] [Abstract][Full Text] [Related]
48. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
[TBL] [Abstract][Full Text] [Related]
49. Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions.
Watanabe R; Higashi S; Nonaka T; Kawakami I; Oshima K; Niizato K; Akiyama H; Yoshida M; Hasegawa M; Arai T
Acta Neuropathol Commun; 2020 Oct; 8(1):176. PubMed ID: 33115537
[TBL] [Abstract][Full Text] [Related]
50. Unusual clinical presentation and neuropathology in two subjects with fused-in sarcoma (FUS) positive inclusions.
Hartikainen PH; Pikkarainen M; Hänninen T; Soininen H; Alafuzoff I
Neuropathology; 2012 Feb; 32(1):60-8. PubMed ID: 21518013
[TBL] [Abstract][Full Text] [Related]
51. RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.
Hofmann JW; Seeley WW; Huang EJ
Annu Rev Pathol; 2019 Jan; 14():469-495. PubMed ID: 30355151
[TBL] [Abstract][Full Text] [Related]
52. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
[TBL] [Abstract][Full Text] [Related]
53. Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain.
Aoki N; Higashi S; Kawakami I; Kobayashi Z; Hosokawa M; Katsuse O; Togo T; Hirayasu Y; Akiyama H
Acta Neuropathol; 2012 Sep; 124(3):383-94. PubMed ID: 22526020
[TBL] [Abstract][Full Text] [Related]
54. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.
Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M
Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033
[No Abstract] [Full Text] [Related]
55. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.
Foulds PG; Davidson Y; Mishra M; Hobson DJ; Humphreys KM; Taylor M; Johnson N; Weintraub S; Akiyama H; Arai T; Hasegawa M; Bigio EH; Benson FE; Allsop D; Mann DM
Acta Neuropathol; 2009 Nov; 118(5):647-58. PubMed ID: 19823856
[TBL] [Abstract][Full Text] [Related]
56. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
57. Signature laminar distributions of pathology in frontotemporal lobar degeneration.
Ohm DT; Cousins KAQ; Xie SX; Peterson C; McMillan CT; Massimo L; Raskovsky K; Wolk DA; Van Deerlin VM; Elman L; Spindler M; Deik A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol; 2022 Mar; 143(3):363-382. PubMed ID: 34997851
[TBL] [Abstract][Full Text] [Related]
58. Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers.
Cousins KAQ; Shaw LM; Chen-Plotkin A; Wolk DA; Van Deerlin VM; Lee EB; McMillan CT; Grossman M; Irwin DJ
JAMA Neurol; 2022 Nov; 79(11):1155-1164. PubMed ID: 36215050
[TBL] [Abstract][Full Text] [Related]
59. Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology.
Scarioni M; Gami-Patel P; Timar Y; Seelaar H; van Swieten JC; Rozemuller AJM; Dols A; Scarpini E; Galimberti D; ; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
Ann Neurol; 2020 Jun; 87(6):950-961. PubMed ID: 32281118
[TBL] [Abstract][Full Text] [Related]
60. Neuropathological background of phenotypical variability in frontotemporal dementia.
Josephs KA; Hodges JR; Snowden JS; Mackenzie IR; Neumann M; Mann DM; Dickson DW
Acta Neuropathol; 2011 Aug; 122(2):137-53. PubMed ID: 21614463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]